Kinda quiet, waiting on their annual report and the quarterly is due out too. I think the stock was about .14 a year ago and much higher before then. Pending FDA approval of their device, this stock could hit dollars. Updates expected before end of month. It is penny stock however, so you know the risks...
If you look into the backers of this company, I think it would be a lot easier to see if this company is "solid" or not.
There is a former Apple Exec, Brad Vroom, that has been backing this company since 2012.... he still has a Apple Park/Campus address (Formerly Apple HQ). Not only Brad Vroom but there are others also listed on OTCQB Certification for 2018... 2017 shows % owned by each person and it was a good amount. https://backend.otcmarkets.com/otcapi/company/financial-report/203332/content
Then there are the Advisers/Consultants that Cerebain has hired that I think have brought a lot to the table for Cerebain also.. http://www.cerebain.com/investorsmedia/ Read the PR's and look into the names of the Consultants/Advisers.
I know its a OTC Stock, but I like to look into the backers/management when I buy... and they are good (IMO).
Also there were restricted shares issued, about 80 million I believe, on or about 10-15-2019.
The only downside that ive seen is that the company hasn't reported anything in about 50 days..... IR @ Cerebain has been trying to let us know to be patient here, and has stressed to us that the company is committed to file their Annual Report.
Huge upside potential here, with very little risk. Im not sure if I would buy out the ask, but if I can afford to lose that amount I sure would be thinking about it also.
News 
Market Data 
Discover 
